Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
This study has been completed.
Study NCT00005811 Information provided by National Cancer Institute (NCI)
First Received on June 2, 2000. Last Updated on February 20, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
AIDS-related Lymphoblastic Lymphoma
AIDS-related Primary CNS Lymphoma
HIV-associated Hodgkin Lymphoma
Leptomeningeal Metastases
Recurrent Childhood Medulloblastoma
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
Hodgkin Disease
Leukemia
Leukemia, Lymphoid
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Lymphoma
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Medulloblastoma
Meningeal Carcinomatosis
Meningeal Neoplasms
Neoplasm Metastasis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
More general conditions related to this trial
Central Nervous System Neoplasms
Glioma
Immune System Diseases
Immunologic Deficiency Syndromes
Immunoproliferative Disorders
Lentivirus Infections
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Processes
Nervous System Diseases
Nervous System Neoplasms
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
topotecan hydrochloride
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Topotecan
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
